Sprint Bioscience AB (OSTO:SPRINT) EV-to-Revenue : 0.75 (As of May. 23, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sprint Bioscience AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sprint Bioscience AB's enterprise value is kr51.29 Mil. Sprint Bioscience AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr68.36 Mil. Therefore, Sprint Bioscience AB's EV-to-Revenue for today is 0.75.

The historical rank and industry rank for Sprint Bioscience AB's EV-to-Revenue or its related term are showing as below:

OSTO:SPRINT' s EV-to-Revenue Range Over the Past 10 Years
Min: -103.27 Med: 5.46 Max: 3213.83
Current: 0.74

During the past 13 years, the highest EV-to-Revenue of Sprint Bioscience AB was 3213.83. The lowest was -103.27. And the median was 5.46.

OSTO:SPRINT's EV-to-Revenue is ranked better than
89.71% of 1040 companies
in the Biotechnology industry
Industry Median: 8.12 vs OSTO:SPRINT: 0.74

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Sprint Bioscience AB's stock price is kr1.306. Sprint Bioscience AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.98. Therefore, Sprint Bioscience AB's PS Ratio for today is 1.33.

Sprint Bioscience AB EV-to-Revenue Historical Data

The historical data trend for Sprint Bioscience AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sprint Bioscience AB EV-to-Revenue Chart

Sprint Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

4.24

8.64

3.43

1.41

Sprint Bioscience AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															545.23	519.03	2.12	1.41	0.47

Competitive Comparison of Sprint Bioscience AB's EV-to-Revenue

For the Biotechnology subindustry, Sprint Bioscience AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sprint Bioscience AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sprint Bioscience AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sprint Bioscience AB's EV-to-Revenue falls into.

Sprint Bioscience AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sprint Bioscience AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	51.294	/	68.356
	=	0.75

Sprint Bioscience AB's current Enterprise Value is kr51.29 Mil.
Sprint Bioscience AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr68.36 Mil.

Sprint Bioscience AB (OSTO:SPRINT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sprint Bioscience AB's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.306	/	0.98
	=	1.33

Sprint Bioscience AB's share price for today is kr1.306.
Sprint Bioscience AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.98.

Sprint Bioscience AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sprint Bioscience AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sprint Bioscience AB (OSTO:SPRINT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sprint Bioscience AB (OSTO:SPRINT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

5JA1:Germany

Address

Halsovagen 7, Floor 8, Elevator A, Novum, Huddinge, SWE, 141 57

Website

http://www.sprintbioscience.com

Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.

Sprint Bioscience AB (OSTO:SPRINT) Headlines

No Headlines